Exparel and other local anesthetics

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Tue, 05/22/2018 - 08:51
#1
Breanne Piazik
Breanne Piazik's picture
Offline
Last seen: 3 days 11 hours ago
Joined: 07/27/2014 - 13:05
Exparel and other local anesthetics

We have recently expanded our indications for exparel (liposomal bupivacaine) and have had a few near misses with other products containing local anesthetics within the 96 hour window. In one case a compounded preparation containing ropivacaine was ordered and prepared for a patient who had received exparel pre-op. In another case, an epidural order was placed for a patient with exparel on their profile. We have had several instances of patients receiving lidocaine patches after exparel administration (which the exparel manufacturer does not support.) With so many moving parts, I am wondering what other institutions are doing to prevent these occurrences. Any information or ideas would be greatly appreciated.

Thanks,
Breanne

Breanne Piazik, PharmD, MPH, BCPS
Medication Safety Officer
Elliot Health System
Manchester, NH 03103
603-663-3253

Tags: 

Top